MNKD
Price
$6.96
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
110 days until earnings call
TGTX
Price
$34.90
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
110 days until earnings call
Ad is loading...

MNKD vs TGTX

Header iconMNKD vs TGTX Comparison
Open Charts MNKD vs TGTXBanner chart's image
MannKind
Price$6.96
Change-$0.00 (-0.00%)
Volume$2.42M
CapitalizationN/A
TG Therapeutics
Price$34.90
Change-$0.00 (-0.00%)
Volume$9.89M
CapitalizationN/A
MNKD vs TGTX Comparison Chart
Loading...
MNKD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
MNKD vs. TGTX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNKD is a StrongBuy and TGTX is a StrongBuy.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (MNKD: $6.96 vs. TGTX: $34.90)
Brand notoriety: MNKD and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNKD: 108% vs. TGTX: 251%
Market capitalization -- MNKD: $1.92B vs. TGTX: $5.43B
MNKD [@Biotechnology] is valued at $1.92B. TGTX’s [@Biotechnology] market capitalization is $5.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.77B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNKD’s FA Score shows that 1 FA rating(s) are green whileTGTX’s FA Score has 0 green FA rating(s).

  • MNKD’s FA Score: 1 green, 4 red.
  • TGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MNKD is a better buy in the long-term than TGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNKD’s TA Score shows that 2 TA indicator(s) are bullish while TGTX’s TA Score has 5 bullish TA indicator(s).

  • MNKD’s TA Score: 2 bullish, 6 bearish.
  • TGTX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TGTX is a better buy in the short-term than MNKD.

Price Growth

MNKD (@Biotechnology) experienced а -6.45% price change this week, while TGTX (@Biotechnology) price change was +28.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.83%. For the same industry, the average monthly price growth was +3.51%, and the average quarterly price growth was +5.54%.

Reported Earning Dates

MNKD is expected to report earnings on Mar 04, 2025.

TGTX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-1.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($5.43B) has a higher market cap than MNKD($1.92B). MNKD has higher P/E ratio than TGTX: MNKD (87.06) vs TGTX (39.56). TGTX YTD gains are higher at: 104.333 vs. MNKD (91.209). TGTX has less debt than MNKD: TGTX (112M) vs MNKD (268M).
MNKDTGTXMNKD / TGTX
Capitalization1.92B5.43B35%
EBITDAN/AN/A-
Gain YTD91.209104.33387%
P/E Ratio87.0639.56220%
RevenueN/AN/A-
Total CashN/AN/A-
Total Debt268M112M239%
FUNDAMENTALS RATINGS
MNKD vs TGTX: Fundamental Ratings
MNKD
TGTX
OUTLOOK RATING
1..100
7525
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
1952
SMR RATING
1..100
10066
PRICE GROWTH RATING
1..100
3735
P/E GROWTH RATING
1..100
83100
SEASONALITY SCORE
1..100
2850

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MNKD's Valuation (76) in the Biotechnology industry is in the same range as TGTX (85). This means that MNKD’s stock grew similarly to TGTX’s over the last 12 months.

MNKD's Profit vs Risk Rating (19) in the Biotechnology industry is somewhat better than the same rating for TGTX (52). This means that MNKD’s stock grew somewhat faster than TGTX’s over the last 12 months.

TGTX's SMR Rating (66) in the Biotechnology industry is somewhat better than the same rating for MNKD (100). This means that TGTX’s stock grew somewhat faster than MNKD’s over the last 12 months.

TGTX's Price Growth Rating (35) in the Biotechnology industry is in the same range as MNKD (37). This means that TGTX’s stock grew similarly to MNKD’s over the last 12 months.

MNKD's P/E Growth Rating (83) in the Biotechnology industry is in the same range as TGTX (100). This means that MNKD’s stock grew similarly to TGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MNKDTGTX
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 9 days ago
0%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
MNKD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X90584.1640002628.351600
+2.99%
Bitcoin cryptocurrency
TSLA330.241.75
+0.53%
Tesla
AAPL225.120.89
+0.40%
Apple
SPY597.190.29
+0.05%
SPDR® S&P 500® ETF Trust
GME26.46-0.38
-1.42%
GameStop Corp

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with NTLA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
-1.69%
NTLA - MNKD
47%
Loosely correlated
-3.24%
QSI - MNKD
43%
Loosely correlated
+2.06%
CRSP - MNKD
42%
Loosely correlated
-1.85%
DNLI - MNKD
42%
Loosely correlated
-0.87%
BEAM - MNKD
42%
Loosely correlated
-1.57%
More

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with EDIT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
+12.91%
EDIT - TGTX
50%
Loosely correlated
-3.58%
NTLA - TGTX
42%
Loosely correlated
-3.24%
ALT - TGTX
40%
Loosely correlated
+0.32%
CRNX - TGTX
39%
Loosely correlated
+0.24%
MNKD - TGTX
38%
Loosely correlated
-1.69%
More